The Commercialization Committee shall be composed of at least 2 members, to be appointed from the Board members. The current members are Lauren Barnes (Chairman), Peter Benson and Hans Maier.
The Commercialization Committee is a preparatory organ within the Board with the main duties to:
- prepare resolutions to be adopted by the Board pertaining to matters regarding overall commercialization plans and key commercialization decisions of products within Ascelia; and
- oversee launch readiness; and
- oversee that commercialization capabilities are available timely and adequately according to agreed plans.